Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2022-08-02 00:00:00 ET · period of report 2022-08-01 · accession 0000899243-22-027454 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-02 | 2022-08-01 | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $5.00 | +6,000 | 789.1K | +0.8% | +$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | P | A | 6,000 | $5.00 | 789,121 | D | — | — |